Loading...
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study
Clinical studies based on novel rationales and mechanisms of action of chemotherapy agents and cytokines can contribute to the development of new concepts and strategies of antitumor combination therapies. In previous studies, we investigated the paradoxical immunostimulating effects of some chemoth...
Saved in:
Published in: | Front Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Frontiers Media S.A.
2020
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7069350/ https://ncbi.nlm.nih.gov/pubmed/32211314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00202 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|